← Contracts
PT
1732/2025- Aquisição de L53 - Letrozol [2,5mg; comp] e R1117- Ranibizumab (intravítreo) [10 mg/ ml; 0,165 ml; seringa] doentes em tratamento.
ID 11724177
· Portal BASE
Price
Base Price
€19,693
.00
Effective Price
€474
.00
-97.6%
Contract Details
- Contract Type
- Aquisição de bens móveis
- Procedure
- Ajuste Direto Regime Geral
- CPV Code
- 33600000
- Location
- Portugal, Lisboa, Lisboa
- Bidder Count
- —
Winner
NOVARTIS FARMA - PRODUTOS FARMACÊUTICOS S.A.
NIF 500063524
Dates
- Publication
- 16 Sep 2025
- Celebration
- 08 Sep 2025
Contracting Entity
Centro Hospitalar de Lisboa Ocidental, EPE
NIF 507618319
Public body
Data Source
Portal BASE
Api
· synced 2026-04-17
Risk Flags
Score 45 · MEDIUM RISK
A5 · Threshold Splitting
A5_THRESHOLD_SPLITTING
- Base price
- 19693.0
- Threshold
- 20000.0
- Rule
- A5 threshold splitting: price within 5% below 20000.0
Detected 2026-03-06
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
- Base price
- 19693.0
- Total effective price
- 474.0
- Ratio
- 0.0241
- Direction
- reduction
- Rule
- A9 price reduction: ratio 0.0241 outside [0.5, 1.5]
Detected 2026-03-06